In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent news about the use of artificial intelligence (AI) tools in healthcare.

Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered due to the upcoming Labor Day holiday. To ensure specimen stability and prevent delays, follow the guidelines outlined below for domestic clients and international clients.

A random urine test panel aids in diagnosing mast cell activation syndrome (MCAS), a complex condition often misdiagnosed due to overlapping symptoms. The panel improves access, speeds up diagnosis, and enables individualized treatment by detecting key mast cell mediators.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. In this episode, Dr. Morice and Dr. Pritt review the VALID Act — a piece of legislation currently under consideration in Congress that could lead to significant changes in the oversight of clinical laboratories in the U.S.

Top highlights include: Monoclonal and oligoclonal anti-Platelet Factor 4 antibodies mediate VITT.

Elitza Theel, Ph.D., director of the Infectious Diseases Serology Lab at Mayo Clinic, joins the "Answers From the Lab" podcast for a discussion with Bobbi Pritt, M.D. about tick-borne disease testing. In this episode, Dr. Theel and Dr. Pritt look at emerging tick-borne illnesses, the tests available to detect these infections, and how to prevent them.

Topics include: COVID-19 update, tips for navigating a return to work with long COVID, and COVID-19 booster vaccinations extended to kids 5-11.

Today's highlights include: US at risk of COVID-19 drug shortages this summer, Rochester startup Vyriad developing cancer-fighting viruses, and CDC expresses concern about possibility of undetected monkeypox spread in U.K.

In this special episode of “Lab Medicine Rounds,” Isabella Dishong, president of PathSIG and fourth-year medical student, asks Dr. Justin Kreuter questions from the PathSIG community of medical students who matched into pathology residency.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. In this episode, Dr. Morice and Dr. Pritt discuss legislation under consideration in Congress that could have significant impact on laboratory medicine in the U.S.

This “phlebotomy webinar” will provide basic information on blood compatibility, the consequences of incompatibility and the recognition of an acute hemolytic transfusion reaction.

In her role as a proposal writer, Lisa Wortman Raring helps show clients everything Mayo Clinic Laboratories has to offer, making it clear how the organization can best meet their needs and the needs of their patients.

Alicia Algeciras, Ph.D., describes Mayo Clinic Laboratories’ new blood test to detect NFLC, or neurofilament light chain protein. NFLC is a biomarker for several neurodegenerative conditions. The new assay can determine if a patient’s cognitive decline is due to a neurodegenerative condition or some other, reversible condition — while avoiding the need for more-invasive testing of cerebrospinal fluid.

Top highlights include: Rapid exclusion of acute myocardial injury and infarction with a high sensitivity cardiac troponin T in the emergency department.

Recognizing Dr. Pritt’s innovative work in medical education, the Infectious Diseases Society of America is highlighting her role as an educator in its monthly series.